Gateway funds Phase I and II patient-centered cancer clinical trials that have the potential to shift the paradigm for standard of care. We strive to fund treatment-based studies at the bedside, including all types of cancers.  

We advance our mission by funding Phase I and II patient-centered clinical trials focusing on the following priority research areas:

  • Biomarkers/Molecular Markers (genomic or proteomic)
  • Gene Therapy
  • Histology Agnostic/Basket Trial
  • Immunotherapy
  • Targeted Therapies

Our focus is on the following therapeutic areas:

  • New Investigational Therapies
  • Novel Use or Approach
  • Precision Medicine
  • Integrative Medicine

We seek to bring urgency to the process of cancer research for those patients who are looking for treatments today and are faced with difficult decisions without innovative live-saving options.  Gateway will place increasing emphasis on the funding patient centered and novel research that includes approaches with a high potential for success.

Please send any feedback you may have to For technical support, please click the information icon in the upper right corner.


Sign Up